(Press-News.org) Black women have higher recurrence and mortality rates than non-Hispanic white women for certain types of breast cancer, according to a University of Illinois Chicago researcher's study published recently in JAMA Oncology.
Dr. Kent Hoskins, associate professor in the UIC College of Medicine's division of hematology/oncology, and co-leader of the Breast Cancer Research group in the University of Illinois Cancer Center, published the study, "Association of race/ethnicity and the 21-gene Recurrence Score with breast cancer-specific mortality among US women" in the Jan. 21 online issue.
Hoskins and the research team sought to discover if breast cancer-specific mortality among women with estrogen receptor-positive, axillary node-negative breast cancer differs by race within risk categories defined by the Oncotype Recurrence Score, or RS, which is a genomic test that analyzes the activity of a group of genes that can affect how a cancer is likely to behave and respond to treatment. They also wanted to find out if the prognostic accuracy of the RS differs by race.
"Using data from the national SEER registry that included more than 70,000 patients across the U.S., we found there was a much higher mortality rate for African American women with the most common subtype of breast cancer event when they are diagnosed at an early stage," Hoskins said.
Women with hormone-dependent breast cancer typically have a favorable prognosis, but Hoskins found that even after adjusting for age at diagnosis, tumor stage and treatment, there is still a significant mortality gap between Black and non-Hispanic white women with axillary node-negative, hormone-dependent tumors that have a comparable RS.
The research also found that Black women are more likely to have a high-risk RS, indicating that Black women disproportionately develop biologically aggressive tumors. According to Hoskins, the underlying cause of this is unknown, but this is an active area of research among UI Cancer Center investigators. The Oncotype test also had lower prognostic accuracy in Black women, indicating that genomic tumor tests used to identify candidates for chemotherapy may require re-calibration in populations with greater racial and ethnic diversity, according to Hoskins' research.
The paper's findings are based on a retrospective, population-based cohort study database that contained data on women 18 years and older who were diagnosed with first primary stages I-III, estrogen receptor-positive breast cancer between 2004-2015.
"This study highlights a widespread problem that may contribute to health disparities," Hoskins said. "Research to develop and validate new medical tests frequently have inadequate representation of individuals from racial/ethnic minority groups. Because of this, new tests may be less accurate in individuals who belong to minority groups."
Because the RS is used by oncologists to make informed treatment decisions on the need for chemotherapy, Hoskins' study points out that the Oncotype RS model needs to be recalibrated to reflect racial differences.
The same lack of adequate representation of individuals from racial/ethnic minority groups plagues clinical trials of new cancer treatments, according to Hoskins.
"Our study is just one more example of how exclusion of minority patients from research can lead to inequities in health outcomes," he said.
While the study concluded that there is a disparity in mortality among Black women with early-stage breast cancer, further research is needed to understand the role of tumor biology and of structural violence in this disparity. Structural violence refers to systematic ways in which social structures harm or otherwise disadvantage individuals. Hoskins said the next step is to look at population health data and molecular data to determine the mechanisms driving the differences.
"We really think there is an intersection between social determinants of health and tumor biology and that is what we are trying to understand with follow-up studies," Hoskins said.
In addition to Hoskins, the research team included Dr. Oana Danciu and Dr. Gregory Calip, who are both UI Cancer Center members, and Dr. Naomi Ko of Boston University.
INFORMATION:
Simon Fraser University researchers have found evidence that large ambush-predatory worms--some as long as two metres--roamed the ocean floor near Taiwan over 20 million years ago. The finding, published today in the journal Scientific Reports, is the result of reconstructing an unusual trace fossil that they identified as a burrow of these ancient worms.
According to the study's lead author, SFU Earth Sciences PhD student, Yu-Yen Pan, the trace fossil was found in a rocky area near coastal Taiwan. Trace fossils are part of a research field known as ichnology. "I was fascinated by this monster burrow at first glance," she says. "Compared to other trace fossils which are usually only a few tens of centimetres ...
A new collaborative study from researchers at the Geisel School of Medicine at Dartmouth and the University of Washington (UW) and published in the Proceedings of the National Academy of Sciences (PNAS), reveals unexpected insights into how skin exposure to ultraviolet (UV) light can worsen clinical symptoms in autoimmune diseases such as lupus.
Lupus, an autoimmune disease that can cause inflammation of the joints, skin, kidneys, blood cells, brain, heart and lungs, is caused when the immune system attacks its own tissue.
Previous research has established that in up to 80 percent of lupus patients, sunlight exposure can trigger both local skin inflammation and systemic flares, including kidney disease. But little has been understood about the underlying mechanisms that drive this process. ...
Doctors may be able to predict their patients' risks of fatal coronary heart disease more accurately by taking into account the number of adverse social factors affecting them, according to a new study led by researchers at Weill Cornell Medicine and NewYork-Presbyterian.
The researchers, whose findings appear Dec. 3 in Circulation, analyzed data from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study that tracked cardiovascular-related health outcomes in more than 20,000 people for a decade. The new analysis showed that participants who had more adverse social determinants ...
The SARS-CoV-2 virus may enter and replicate in human cells by exploiting newly-identified sequences within cell receptors, according to work from two teams of scientists. The findings from both groups paint a more complete portrait of the various cellular processes that SARS-CoV-2 targets to not only enter cells, but to then multiply and spread. The results also hint that the sequences could potentially serve as targets for new therapies for patients with COVID-19, although validation in cells and animal models is needed. Scientists know that SARS-CoV-2 binds the ACE2 receptor on the surface of human cells, after which it enters the cell through a process known as endocytosis. Research has suggested that the virus may hijack or interfere with other processes such as cellular housekeeping ...
Chimeric Antigen Receptor T-cell therapy--CAR T--has revolutionized leukemia treatment. Unfortunately, the therapy has not been effective for treating solid tumors including childhood cancers such as neuroblastoma. Preclinical studies using certain CAR T against neuroblastoma revealed toxic effects. Now, a group of scientists at Children's Hospital Los Angeles have developed a modified version of CAR T that shows promise in targeting neuroblastoma, spares healthy brain tissue and more effectively kills cancer cells. Their study was published today in END ...
Astronomers at the Center for Astrophysics | Harvard & Smithsonian have detected the first Jupiter-like planet without clouds or haze in its observable atmosphere. The END ...
Friends are more than just trusted confidantes, say Michigan State University researchers who have examined the cultural and health benefits of close human relationships in a new study.
"Friendships are one of the untapped resources people can draw on to pursue a happier and healthier life. They literally cost nothing and have health and well-being benefits," said William Chopik, an assistant professor of psychology at MSU and the study's senior author.
Published in Frontiers of Psychology, the study is the largest of its kind and included 323,200 participants from 99 countries. Prior studies compared only a few specific cultures to one another -- but ...
The year 2021 marks the 100th anniversary of a fundamental discovery that's taught in every biochemistry textbook. In 1921, German physician Otto Warburg observed that cancer cells harvest energy from glucose sugar in a strangely inefficient manner: rather than "burn" it using oxygen, cancer cells do what yeast do -- they ferment it. This oxygen-independent process occurs quickly, but leaves much of the energy in glucose untapped.
Various hypotheses to explain the Warburg effect have been proposed over the years, including the idea that cancer cells have defective ...
CHAPEL HILL, N.C. - Many organizations are looking at effective ways to communicate the importance of wearing a mask, especially as highly transmissible new strains of coronavirus threaten to cause a surge in infections.
Experts at the University of North Carolina at Chapel Hill suggest positive messages are critical to supporting the effort.
Their findings, described in a study published in December in the International Journal of Environmental Research and Public Health, give public health experts, leaders and communicators critical insight to craft messaging that could potentially increase mask usage during the pandemic.
"As science evolved during ...
Abnormally hyperactive areas in the brain may help better predict the onset of Alzheimer's disease, according to findings of a research team led by Université de Montreal psychology professor Sylvie Belleville, scientific Director of the Institut universitaire de gériatrie de Montréal research centre.
Hyperactivation could be an early biomarker of Alzheimer's disease, the researchers say in their study published today in Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, co-authored by Belleville and Nick Corriveau-Lecavalier, a doctoral student she supervises.
Worried about their memory
In their research, ...
